Prolong Pharmaceuticals
Prolong Pharmaceuticals, based in South Plainfield, NJ, develops treatments for life-limiting diseases.
Founded
2005Prolong Pharmaceuticals, based in South Plainfield, NJ, develops treatments for life-limiting diseases.
Prolong Pharmaceuticals, headquartered in South Plainfield, New Jersey, is a clinical-stage biopharmaceutical company founded with the mission to develop transformative treatments for life-limiting diseases. The company's vision centers on improving the quality of life for patients by addressing complex diseases and unmet medical needs. Prolong's product pipeline includes treatments for ischemia and hypoxia within stroke, sickle cell disease, and cystic fibrosis.
Notable figures associated with Prolong Pharmaceuticals include its team of experienced scientists and industry experts. The company has garnered attention from significant investors in the biopharmaceutical sector. Key achievements include advancing several products to clinical stages, demonstrating their commitment to innovative medical solutions. Prolong Pharmaceuticals' impact lies in its potential to significantly improve patient outcomes and reduce healthcare costs associated with chronic and debilitating conditions.
Companies similar to Prolong Pharmaceuticals include Prolung, Inception Sciences, PleoPharma and Plumb Pharmaceuticals.
Prolong Pharmaceuticals was founded in 2005.
Prolong Pharmaceuticals' headquarters is located in South Plainfield, NJ, US.
Prolong Pharmaceuticals' most recent funding round was for $30M (USD) in October 2010.
As of Oct 14, 2010, Prolong Pharmaceuticals has disclosed funding of $30M (USD). Undisclosed round amounts are excluded.
Prolong Pharmaceuticals has 75 employees as of Feb 4, 2024.
Plumb Pharmaceuticals
plumbpharma.com
